Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH)
CUSIP: 30050B101
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Class A Common Stock, par value $0.01 per share
- Shares outstanding
- 112,318,617
- Total 13F shares
- 122,283,963
- Share change
- -7,560,479
- Total reported value
- $1,375,271,472
- Put/Call ratio
- 71%
- Price per share
- $11.25
- Number of holders
- 237
- Value change
- -$248,054,960
- Number of buys
- 133
- Number of sells
- 137
Quarterly Holders Quick Answers
What is CUSIP 30050B101?
CUSIP 30050B101 identifies EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 30050B101:
Top shareholders of EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
11%
|
12,595,459
|
$356,199,581 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.7%
|
10,911,418
|
$308,574,901 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
7.8%
|
8,798,311
|
$248,816,236 | — | 30 Sep 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
13D/G
|
Company |
3.1%
from 13D/G
|
8,514,862
|
$240,800,297 | — | 30 Sep 2024 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
4.4%
|
4,939,306
|
$139,683,574 | — | 30 Sep 2024 | |
| FMR LLC |
13F
|
Company |
3.9%
|
4,332,229
|
$122,515,450 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3.7%
|
4,116,045
|
$116,401,751 | — | 30 Sep 2024 | |
| Engaged Capital LLC |
13F
|
Company |
3.6%
|
3,989,468
|
$112,822,155 | — | 30 Sep 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
3.4%
|
3,804,104
|
$107,580,061 | — | 30 Sep 2024 | |
| Granahan Investment Management, LLC |
13F
|
Company |
3.1%
|
3,491,817
|
$98,748,585 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
2,725,375
|
$77,073,605 | — | 30 Sep 2024 | |
| Bellevue Group AG |
13F
|
Company |
2.4%
|
2,670,050
|
$75,509,014 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.2%
|
2,520,818
|
$71,303,055 | — | 30 Sep 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.2%
|
2,431,218
|
$68,762,246 | — | 30 Sep 2024 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
2.1%
|
2,371,052
|
$67,053,000 | — | 30 Sep 2024 | |
| First Light Asset Management, LLC |
13F
|
Company |
2%
|
2,298,261
|
$64,994,821 | — | 30 Sep 2024 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
1.9%
|
2,156,115
|
$60,974,918 | — | 30 Sep 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
1.8%
|
2,070,000
|
$58,539,600 | — | 30 Sep 2024 | |
| Holocene Advisors, LP |
13F
|
Company |
1.8%
|
2,044,606
|
$57,821,458 | — | 30 Sep 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.7%
|
1,898,399
|
$53,686,716 | — | 30 Sep 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.5%
|
1,665,115
|
$47,089,452 | — | 30 Sep 2024 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
1.4%
|
1,516,544
|
$42,887,870 | — | 30 Sep 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.3%
|
1,495,385
|
$42,289,489 | — | 30 Sep 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.3%
|
1,420,387
|
$40,168,544 | — | 30 Sep 2024 | |
| Camber Capital Management LP |
13F
|
Company |
1.2%
|
1,400,000
|
$39,592,000 | — | 30 Sep 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
1.2%
|
1,380,184
|
$39,031,634 | — | 30 Sep 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.2%
|
1,364,298
|
$38,582,348 | — | 30 Sep 2024 | |
| NORGES BANK |
13F
|
Company |
1.2%
|
1,347,256
|
$38,100,400 | — | 30 Sep 2024 | |
| Invesco Ltd. |
13F
|
Company |
1.2%
|
1,293,345
|
$36,575,798 | — | 30 Sep 2024 | |
| Hood River Capital Management LLC |
13F
|
Company |
1.2%
|
1,292,379
|
$36,548,478 | — | 30 Sep 2024 | |
| Boston Partners |
13F
|
Company |
1.1%
|
1,272,702
|
$35,053,888 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
1,177,814
|
$33,308,581 | — | 30 Sep 2024 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
0.89%
|
998,260
|
$28,230,793 | — | 30 Sep 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.81%
|
912,395
|
$25,802,531 | — | 30 Sep 2024 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.81%
|
909,776
|
$24,682,223 | — | 30 Sep 2024 | |
| Frank J. Williams |
3/4/5
|
Director |
—
mixed-class rows
|
903,126
mixed-class rows
|
$24,140,121 | — | 01 Jun 2023 | |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC |
13F
|
Company |
0.67%
|
753,038
|
$21,295,915 | — | 30 Sep 2024 | |
| GABELLI FUNDS LLC |
13F
|
Company |
0.64%
|
721,500
|
$20,404,020 | — | 30 Sep 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.64%
|
715,905
|
$20,247,000 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.63%
|
702,545
|
$19,867,973 | — | 30 Sep 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.62%
|
694,234
|
$19,632,937 | — | 30 Sep 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.58%
|
646,806
|
$18,291,674 | — | 30 Sep 2024 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.57%
|
639,000
|
$18,070,920 | — | 30 Sep 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.56%
|
631,584
|
$17,861,000 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.54%
|
610,746
|
$17,271,897 | — | 30 Sep 2024 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
0.45%
|
503,823
|
$14,248,113 | — | 30 Sep 2024 | |
| Man Group plc |
13F
|
Company |
0.44%
|
491,382
|
$13,896,283 | — | 30 Sep 2024 | |
| Rock Point Advisors, LLC |
13F
|
Company |
0.41%
|
465,782
|
$13,172,315 | — | 30 Sep 2024 | |
| HARBOR CAPITAL ADVISORS, INC. |
13F
|
Company |
0.38%
|
422,421
|
$11,946,000 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.37%
|
420,321
|
$11,886,678 | — | 30 Sep 2024 |
Institutional Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q4 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.